Data is not available at this time.
Molten Ventures VCT plc operates as a Venture Capital Trust (VCT) specializing in direct investments across early, mid, and late-stage venture opportunities in the UK. The firm focuses on growth capital investments, primarily targeting the healthcare and software & services sectors. As a VCT, it benefits from tax incentives for UK investors, positioning it as a key player in fostering innovation and scaling high-potential startups. The fund’s strategy emphasizes long-term value creation through active portfolio management and sector expertise, distinguishing it from passive investment vehicles. Its market position is reinforced by a disciplined approach to capital allocation, targeting companies with scalable business models and strong management teams. The UK’s dynamic tech and healthcare ecosystems provide a fertile ground for Molten Ventures, though competition from other VCTs and private equity firms remains intense.
The company reported negative revenue of -£5.0 million and a net loss of -£8.1 million for FY 2024, reflecting the inherent volatility of venture capital investments. Operating cash flow was -£2.1 million, while capital expenditures matched this outflow, indicating reinvestment into portfolio companies. The lack of debt suggests a conservative financial structure, but profitability challenges persist due to the high-risk nature of early-stage investing.
Diluted EPS stood at -3.32p, underscoring the earnings pressure from unrealized portfolio losses or write-downs. The absence of leverage implies reliance on equity capital, which may limit scalability but reduces financial risk. The fund’s capital efficiency hinges on its ability to identify and nurture high-growth startups, though near-term earnings remain subdued by the illiquid nature of venture investments.
Molten Ventures maintains a clean balance sheet with £3.2 million in cash and no debt, providing flexibility to weather market downturns. The zero-debt structure aligns with its long-term investment horizon, though liquidity is constrained by the illiquid nature of venture assets. Shareholders’ equity is primarily tied to the performance of its portfolio, which may fluctuate with valuation cycles.
Despite negative earnings, the company paid a dividend of 2.5p per share, likely sourced from tax-advantaged reserves or realized gains. Growth prospects depend on the success of its portfolio companies, with exit events (IPOs, acquisitions) being critical for future returns. The dividend policy may appeal to income-focused investors, though sustainability relies on portfolio maturation and liquidity events.
With a market cap of ~£109.7 million, the stock trades at a discount to net asset value (NAV), reflecting skepticism about portfolio valuations. The low beta (0.06) suggests minimal correlation with broader markets, typical of venture capital trusts. Investors likely price in prolonged uncertainty, given the early-stage focus and macroeconomic headwinds for tech and healthcare startups.
Molten Ventures’ strategic edge lies in its sector specialization and tax-efficient structure, attracting UK investors. However, the outlook remains contingent on portfolio performance and exit opportunities. A rebound in tech valuations could unlock NAV growth, but near-term challenges persist. The firm’s success will hinge on its ability to navigate funding cycles and deliver exits at favorable multiples.
Company filings, London Stock Exchange data
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |